Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 2,747.37%2.71B | -76.48%669M | 50.66%919M | 147.01%1.76B | -267.62%-642M | -97.56%95M | 77.20%2.84B | -21.79%610M | -2,190.50%-3.74B | -71.25%383M |
Net profit before non-cash adjustment | -17,500.00%-176M | 113.47%97M | -43.99%354M | -157.14%-126M | -468.38%-501M | 99.75%-1M | 23.40%-720M | 1,720.51%632M | 76.67%-49M | -82.61%136M |
Total adjustment of non-cash items | 98.72%2.96B | -40.45%53M | -16.01%829M | 103.95%17M | 144.37%2.06B | -67.78%1.49B | -95.44%89M | -34.02%987M | -743.14%-430M | -31.13%843M |
-Depreciation and amortization | 0.24%2.96B | -6.16%731M | 3.06%774M | 2.19%745M | 2.32%706M | -23.82%2.95B | -43.43%779M | -6.71%751M | -12.69%729M | -19.20%690M |
-Reversal of impairment losses recognized in profit and loss | ---91M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Disposal profit | -381.72%-448M | -1,633.33%-52M | -265.38%-285M | ---117M | 150.00%6M | -205.68%-93M | -105.88%-3M | -388.89%-78M | --0 | -140.00%-12M |
-Other non-cash items | 139.65%542M | 22.13%-535M | 8.28%340M | 47.28%-611M | 716.97%1.35B | -402.57%-1.37B | -67.56%-687M | -52.71%314M | -28.63%-1.16B | -56.00%165M |
Changes in working capital | 94.67%-74M | -85.08%519M | 73.76%-264M | 157.37%1.87B | -268.68%-2.2B | -336.48%-1.39B | 487.50%3.48B | -48.60%-1.01B | -843.28%-3.26B | 11.16%-597M |
-Change in receivables | 28.08%-443M | -81.25%618M | 46.13%-1.7B | 296.79%1.96B | -647.52%-1.33B | -116.13%-616M | 430.92%3.3B | -3,353.61%-3.16B | -145.51%-998M | -90.42%242M |
-Change in inventory | 252.43%2.32B | -0.86%694M | -109.07%-42M | 150.58%693M | 174.03%972M | 10.06%-1.52B | -44.04%700M | 165.67%463M | -50.88%-1.37B | 1.13%-1.31B |
-Change in payables | -249.57%-1.58B | -51.90%-1.24B | -15.16%1.96B | 35.87%-953M | -228.60%-1.35B | 144.08%1.06B | -219.61%-815M | 306.51%2.31B | -2.27%-1.49B | 183.39%1.05B |
-Provision for loans, leases and other losses | -18.77%-367M | 49.83%445M | 22.67%-481M | -71.57%168M | 13.22%-499M | -530.61%-309M | -49.83%297M | 2.35%-622M | -2.64%591M | 5.89%-575M |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -55.69%-383M | 3.33%-87M | -28.77%-94M | -144.19%-105M | -142.50%-97M | -56.69%-246M | -100.00%-90M | -97.30%-73M | -16.22%-43M | -5.26%-40M |
Interest received (cash flow from operating activities) | 12.43%398M | 1.37%74M | 16.80%146M | -5.26%36M | 20.34%142M | 10.28%354M | 23.73%73M | 9.65%125M | -19.15%38M | 16.83%118M |
Tax refund paid | 27.93%-787M | 68.23%-88M | 20.93%-102M | -39.73%-204M | 27.22%-393M | -20.53%-1.09B | -154.13%-277M | 32.81%-129M | 56.80%-146M | -102.25%-540M |
Other operating cash inflow (outflow) | -1,055.88%-975M | -333.33%-21M | -610.00%-51M | -1,770.37%-902M | -103.45%-1M | -70.86%102M | -92.91%9M | -91.38%10M | -34.15%54M | 16.00%29M |
Operating cash flow | 221.73%958M | -78.62%547M | 50.64%818M | 115.21%584M | -1,882.00%-991M | -122.46%-787M | 56.32%2.56B | -30.47%543M | -5,629.85%-3.84B | -104.34%-50M |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 10.40%-1.46B | 18.01%-255M | -30.79%-807M | 89.51%-32M | 7.73%-370M | 55.50%-1.63B | 80.38%-311M | 43.39%-617M | 56.55%-305M | -35.93%-401M |
Net investment product transactions | 1,238.46%740M | 121.59%65M | 247.18%493M | 40.82%138M | 1,200.00%44M | -114.57%-65M | -164.73%-301M | 1,675.00%142M | 415.79%98M | 91.30%-4M |
Net changes in other investments | -38.18%-485M | 18.75%-156M | -706.90%-234M | 2.63%-74M | 61.11%-21M | -51.95%-351M | -113.33%-192M | 32.56%-29M | -130.30%-76M | 16.92%-54M |
Investing cash flow | 41.02%-1.21B | 56.97%-346M | -8.73%-548M | 111.31%32M | 24.40%-347M | 40.70%-2.05B | 33.55%-804M | 55.20%-504M | 60.47%-283M | -13.05%-459M |
Financing cash flow | ||||||||||
Net issuance payments of debt | -3,756.31%-3.77B | -88.48%-1.49B | -464.20%-1.23B | -517.51%-1.98B | 1,051.85%933M | 194.50%103M | -1,212.68%-790M | 218.87%338M | 30.58%474M | 112.48%81M |
Increase or decrease of lease financing | -183.45%-489M | -79.31%-156M | -21.13%-86M | -115.83%-130M | -51.95%-117M | 183.59%586M | 38.30%-87M | 58.24%-71M | 534.39%821M | 61.69%-77M |
Cash dividends paid | -4.18%-299M | --0 | 24.28%-131M | --0 | -47.37%-168M | 37.47%-287M | --0 | 24.78%-173M | --0 | 50.22%-114M |
Net other fund-raising expenses | -2.08%-441M | 1.02%-390M | --372M | ---173M | -557.89%-250M | -644.83%-432M | ---394M | --0 | --0 | 35.59%-38M |
Financing cash flow | -16,550.00%-5B | -40.80%-1.65B | -18,212.50%-1.47B | -276.22%-2.28B | 368.92%398M | 97.74%-30M | -1,570.00%-1.17B | 97.27%-8M | 644.25%1.3B | 86.99%-148M |
Net cash flow | ||||||||||
Beginning cash position | -13.93%15.89B | -19.36%12.81B | -11.98%13.89B | -16.61%15.17B | -13.93%15.89B | -2.00%18.46B | -10.18%15.88B | -13.84%15.78B | -3.74%18.2B | -2.00%18.46B |
Current changes in cash | -82.98%-5.25B | -346.59%-1.45B | -3,954.84%-1.2B | 41.07%-1.67B | -43.07%-940M | -123.98%-2.87B | 64.15%586M | 104.87%31M | -364.20%-2.83B | -68.03%-657M |
Effect of exchange rate changes | 80.47%536M | 68.16%-185M | 64.06%105M | -6.52%387M | -42.75%229M | -67.18%297M | -238.66%-581M | 2,233.33%64M | 1,492.31%414M | -13.61%400M |
Cash adjustments other than cash changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1M | -100.00%-2M |
End cash Position | -29.65%11.18B | -29.65%11.18B | -19.36%12.81B | -11.98%13.89B | -16.61%15.17B | -13.93%15.89B | -13.93%15.89B | -10.18%15.88B | -13.84%15.78B | -3.74%18.2B |
Free cash flow | 60.34%-963M | -96.87%71M | -120.59%-225M | 113.32%552M | -201.77%-1.36B | -490.75%-2.43B | 1,287.96%2.27B | 66.99%-102M | -438.88%-4.14B | -152.56%-451M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |